Medical Oncologist
There is no single price for breast cancer treatment in India. The total cost depends on the stage, the subtype, the exact regimen, the hospital tier and your insurance — so the only honest way to talk about it is in indicative ranges. This guide gives realistic INR ranges for surgery, chemotherapy, radiation, targeted therapy and diagnostics, explains what really drives the bill, and shows practical ways to reduce it through insurance and government schemes. For a costed plan, see our breast cancer treatment in Hyderabad page.
When families first ask "how much does breast cancer treatment cost in India?", they are usually hoping for one number. In reality, breast cancer is not one disease and not one treatment — so the total can range from roughly ₹1.5–3 lakh for a straightforward early-stage case treated with surgery and a short course of treatment, to ₹8–15 lakh or more when chemotherapy, radiation and targeted therapy are all needed over many months. These are indicative ranges only and vary widely by stage, regimen, hospital tier and insurance.
The honest, useful approach is to understand the building blocks — diagnostics, surgery, chemotherapy, radiation and targeted/hormone therapy — and then see which ones your particular plan needs. Your stage and diagnosis determine most of the bill. The sections below break down each component as a range, and the later sections explain how to bring the figure down with insurance, schemes and diagnostic discounts.
Every figure on this page is an indicative range for India in general — not a CION price list. Your actual cost varies by stage, subtype, regimen, city, hospital tier and insurance.
Early-stage disease often needs fewer treatments; advanced disease usually needs the full sequence over many months — so the stage at diagnosis moves the total the most.
Health insurance, ArogyaSri / Ayushman Bharat and diagnostic discounts can cover a large share of the bill — so the "sticker price" is rarely what a family actually pays.
A large part of out-of-pocket breast cancer cost in India comes from late diagnosis — advanced disease needs more treatment over a longer time. Yet many families never use the financial help they qualify for: government schemes like ArogyaSri and Ayushman Bharat PM-JAY can cover cancer treatment at empanelled hospitals, and most health insurance policies cover hospitalisation, day-care chemotherapy and surgery. Always ask about scheme eligibility and cashless cover before treatment begins. Source: ICMR / National Cancer Registry Programme; scheme guidance — verify current eligibility.
Below are realistic, indicative ranges for each part of breast cancer treatment in India. Treat them as a starting point for conversation, not a quote: actual figures vary by stage, regimen, city, hospital tier and insurance. Most patients need a combination of these rather than all of them — and your oncologist decides which apply.
For a plan costed to your reports, our breast cancer treatment in Hyderabad team can give a written estimate during a free consultation.
A breast-conserving surgery or mastectomy typically falls in an indicative range of about ₹1–3 lakh, depending on the procedure, hospital tier and whether reconstruction is added. Sentinel node biopsy and pathology add to this.
Chemotherapy is usually given over several cycles; a typical full course can range broadly from about ₹1–4 lakh depending on the regimen, number of cycles and supportive medicines. Day-care chemo is often covered by insurance.
A full course of radiation therapy commonly falls in an indicative range of about ₹1–3 lakh, varying with the technique used and the number of sessions prescribed by the radiation oncologist.
Targeted therapy (for example HER2-directed treatment) can add substantially over a year and varies widely; oral hormone (endocrine) therapy is comparatively low-cost. Both depend on your subtype and are highly individual.
Before treatment begins, you usually need imaging, a biopsy and pathology, and sometimes staging scans and genetic testing. These diagnostic costs are real but generally smaller than treatment, and they are often where families can save the most — at CION, diagnostics carry discounts of up to 50%. Knowing the typical ranges helps you plan and avoid paying more than you need to.
A mammogram or breast ultrasound is relatively inexpensive; a breast MRI costs more. Indicative ranges run from a few hundred to several thousand rupees each, before any discount.
A breast biopsy with ER/PR/HER2 testing confirms the diagnosis and subtype. Indicative ranges vary by the tests done; this report is essential because it determines almost everything about your plan and cost.
For some patients, staging scans are needed to check whether the cancer has spread. These add to upfront cost but help avoid over- or under-treatment, so they are money well spent when indicated.
A BRCA gene test is recommended in certain situations and can change treatment. It is an added cost, but for the right patient it can unlock targeted options and protect family members.
Two women with "breast cancer" can have very different bills. The reasons are mostly predictable, and understanding them helps you ask the right questions and avoid surprises. None of these are reasons to delay care — early treatment is usually cheaper than late treatment.
Early-stage breast cancer may need surgery and a shorter treatment course; advanced or metastatic disease usually needs ongoing treatment over many months — so stage is the single biggest cost driver.
Hormone-positive, HER2-positive and triple-negative cancers are treated differently. A subtype that needs targeted therapy over a year will cost more than one treated mainly with surgery and hormone tablets.
The same treatment can cost differently in a metro corporate hospital versus a focused cancer centre, and between cities. Ask for an itemised estimate so you can compare like with like.
Hospital stays, supportive medicines and managing side effects add to the total. A well-run team that prevents complications and avoids unnecessary tests often keeps the real-world cost lower.
Cost worries should never delay cancer treatment. CION is a woman-headed, tumor-board-led organisation that pairs transparent, written cost estimates with help navigating insurance and government schemes — so you can focus on the treatment, not the paperwork.
Talk to our team
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Transparent costs, insurance and scheme guidance, and woman-led care across 35+ centres in Telangana & AP. Call 1800-202-8726.
The headline ranges can look frightening, but very few families pay them in full. Between health insurance, government schemes, diagnostic discounts and sensible choices, the real out-of-pocket cost is usually a fraction of the sticker price — provided you set things up before treatment starts rather than after.
The key is to act early: confirm your insurance cover, check eligibility for government schemes like ArogyaSri and Ayushman Bharat, and ask the hospital to arrange cashless treatment wherever possible.
Most families use a combination of routes rather than a single one. Knowing which applies to you — and arranging it before treatment — is the difference between a manageable cost and a stressful one. Here is how the main options compare.
CION's team can review your situation during the free consultation and help you choose the route that protects you best, whether that is cashless insurance, a government scheme, or a combination.
When money is tight, it is tempting to choose treatment purely on the lowest quote. But in cancer care, the goal is the right treatment in the right order — getting it wrong can cost far more later, in both money and health. The most cost-effective path is usually an accurate plan, done well the first time, with complications prevented.
That is what a tumor-board approach is designed to deliver: the right tests (not every test), the right sequence of treatment, and outcomes that justify the spend. CION's published outcomes reflect this focus on doing it properly.
CION breast cancer 1-year survival: 96.9% vs national average 85.4% (+11.5%). *1-year survival. Source: ICMR / National Cancer Registry Programme (NCRP).
You should not have to guess the cost of your treatment. CION offers a clear, woman-led pathway from first consultation to a written, costed plan — built around your stage and reports, with your first consultation free and help arranging insurance or scheme cover.
A specialist reviews your reports in full, explains the likely treatment and outlines what each part involves — no rushed decisions, no unnecessary tests.
Any needed imaging, biopsy or staging is arranged with diagnostic discounts of up to 50%, so the upfront cost of building your plan stays low.
3+ oncologists agree the right treatment sequence, and you receive a transparent, itemised written cost estimate for the whole course.
The team helps you check insurance cover and government scheme eligibility, and supports cashless or reimbursement claims so you pay as little out of pocket as possible.
Hear from patients treated at CION — diagnosis, treatment path, and where they are today.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Talk to our team
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
There is no single price — it depends on the stage, subtype, exact regimen, hospital tier and your insurance. As an indicative guide, a straightforward early-stage case treated mainly with surgery and a short course of treatment may fall in the region of ₹1.5–3 lakh, while a case needing chemotherapy, radiation and targeted therapy over many months can run to ₹8–15 lakh or more. These are broad ranges, not quotes. The most reliable figure comes from an itemised, written estimate based on your own reports. CION provides this during a free consultation, along with help to reduce the cost through insurance, government schemes and diagnostic discounts of up to 50%.
The stage at diagnosis is usually the single biggest driver. Early-stage breast cancer often needs surgery and a shorter treatment course, while advanced or metastatic disease typically needs ongoing treatment over many months — which costs much more. The subtype matters too: a cancer that needs targeted therapy over a year costs more than one treated mainly with surgery and hormone tablets. Hospital tier, city, and the supportive care needed to manage side effects also move the figure. This is one more reason early diagnosis matters: treating breast cancer early is generally far cheaper than treating it late, as well as giving better outcomes.
Most health insurance (mediclaim) policies cover breast cancer hospitalisation, surgery and day-care chemotherapy up to your sum insured, and many allow cashless treatment at network hospitals so you do not pay upfront. The details depend on your policy — watch for waiting periods, pre-existing-disease clauses and sub-limits. Critical-illness or cancer-specific plans pay a lump sum on diagnosis that can cover costs a standard mediclaim does not. Always confirm what is covered before treatment starts. Our insurance coverage guide explains cashless versus reimbursement, day-care chemo cover and claim tips, and the CION team can help you check your policy.
Yes, for eligible families. In Telangana, ArogyaSri can cover cancer treatment at empanelled hospitals; in Andhra Pradesh, Dr. YSR Aarogyasri does the same; and nationally, Ayushman Bharat PM-JAY covers eligible families. These schemes can dramatically reduce or remove out-of-pocket cost for those who qualify and are treated at an empanelled hospital. Eligibility, the packages covered and the list of empanelled hospitals can change, so you should verify your current eligibility and the hospital empanelment before treatment. Our government schemes guide explains the basics, and the CION team can help you check whether you qualify.
Several practical steps help. First, use your health insurance fully and arrange cashless treatment if your hospital is in the network. Second, check eligibility for government schemes such as ArogyaSri, Dr. YSR Aarogyasri or Ayushman Bharat PM-JAY. Third, save on diagnostics — at CION these carry discounts of up to 50%, which lowers the upfront cost of imaging, biopsy and staging. Fourth, avoid late diagnosis and over-testing: treating cancer early is cheaper than treating it late, and a tumor-board plan avoids unnecessary tests. Finally, ask for an itemised written estimate up front so you can plan the whole course rather than face costs month by month.
Chemotherapy is given over several cycles, and the total depends on the regimen chosen for your subtype, the number of cycles, the supportive medicines needed to manage side effects, and whether it is given as day-care or with admission. A short course differs greatly from a longer one, and some regimens use more expensive medicines than others. Because of this, a full course can range broadly as an indicative figure. Day-care chemotherapy is often covered by insurance, which reduces what you pay. Your medical oncologist selects the regimen based on your cancer, not the cost — but you can and should ask for an estimate of the full course before starting.
Not necessarily — and the comparison is more about value than headline price. The same treatment can cost differently between a metro corporate hospital and a focused cancer centre, and between cities. What matters most is getting the right tests and the right treatment sequence the first time, because a wrong or repeated plan costs far more later. A tumor-board approach avoids both under-testing and over-testing, prevents avoidable complications, and so often keeps the real-world cost lower while improving outcomes. Always ask for an itemised estimate so you can compare like with like, and weigh the published outcomes alongside the price.
Yes. CION offers a free first consultation for all cancer patients, including a full 45-minute review of your reports, an explanation of the likely treatment, and a transparent, itemised written cost estimate for the whole course — decisions for healing, not billing. Diagnostics carry discounts of up to 50%, and the team helps you check insurance cover and government scheme eligibility and supports cashless or reimbursement claims. There are no rushed decisions and no unnecessary tests. You can book on 1800-202-8726 or request a callback through the form on this page, and explore costed plans on our breast cancer treatment in Hyderabad page.
Browse our complete guide to breast cancer — types, symptoms, tests and treatments. Tap any topic to read more.